Pavel Strop

Pavel Strop has a diverse work experience in the biotechnology and pharmaceutical industry. Pavel is currently serving as the Vice President and Head of Research at Tallac Therapeutics since September 2021. Previously, Pavel held various positions at Bristol Myers Squibb, including Executive Director of Discovery Biotherapeutics from March 2020 to August 2021, and Senior Director of Protein Engineering from an unknown start date to March 2020. Prior to that, they worked at Pfizer, Oncology-Rinat R&D, where they held roles such as Director of Protein Biochemistry (unknown start and end date), Associate Research Fellow (unknown start and end date), Senior Principal Scientist (unknown start and end date), Principal Scientist (unknown start and end date), and Senior Scientist (unknown start and end date). Pavel's early experience includes working as a Postdoctoral Fellow at Stanford University from 2002 to 2007 and as a Graduate Student at Caltech from 1997 to 2002.

Pavel Strop pursued their undergraduate education from 1993 to 1997 at the University of Arizona, where they earned a Bachelor of Science degree in Biochemistry. Pavel then went on to pursue further studies at Caltech from 1997 to 2002, where they completed a Ph.D. degree in Biochemistry and Molecular Biophysics.